Similar articles

• [Platelet function disorders and ischemic cerebral accidents. Therapeutic prospects].

  Géraud J, Rascol A, Bierme R, Boneu B, Guiraud B, Fernet P, Géraud G, David J. Géraud J, et al. Rev Neurol (Paris). 1972 Jan;126(1):31-40. Rev Neurol (Paris). 1972. PMID: 4635139 French. No abstract available.
• [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].

  Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson JE, Olsson O, Thornberg A. Brechter C, et al. Lakartidningen. 1980 Dec 24;77(52):4947-56. Lakartidningen. 1980. PMID: 7010029 Clinical Trial. Swedish. No abstract available.
• Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.

  Serebruany VL, Malinin AI, Pokov AN, Hanley DF. Serebruany VL, et al. Clin Ther. 2008 Feb;30(2):249-59. doi: 10.1016/j.clinthera.2008.02.006. Clin Ther. 2008. PMID: 18343263 Clinical Trial.
• Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.

  Biller J. Biller J. J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19. J Neurol Sci. 2009. PMID: 19380153 Review.
• Platelet inhibitors for TIAs. A review of prospective drug trial results.

  Ramirez-Lassepas M. Ramirez-Lassepas M. Postgrad Med. 1984 Apr;75(5):52-62. doi: 10.1080/00325481.1984.11697988. Postgrad Med. 1984. PMID: 6369285 Review. No abstract available.